Original Title: Vaccination mod rotavirus – en medicinsk teknologivurdering

Authors' recommendations: In conclusion, two very effective and safe vaccines have convincing preventive effectiveness in relation to morbidity measured by the number of cases of diarrhoea, physician consultations and hospital admissions. Implementing vaccination against rotavirus is a rational intervention based on a socioeconomic perspective that includes the societal value of parents' absence from work. In contrast, the cost of implementing vaccination against rotavirus would not be offset by a similar reduction in treatment costs, and the intervention would thus not save money within the narrow perspective of the health sector. Implementing the two-dose vaccination in the current childhood vaccination programme would be the simplest and least expensive option, but public procurement tendering in accordance with European Union rules with the participation of both vaccine manufacturers would probably reduce the final cost of the vaccine considerably. Many of the parents who participated in the qualitative interviews as part of investigating the perspectives of citizens and patients said that they do not consider acute gastroenteritis to be severe enough to warrant implementing vaccination against rotavirus in Denmark's childhood vaccination programme and raised the issue of a possible satura-tion point for vaccination. Based on this and based on the views expressed by the Danish Health and Medicines Authority on Denmark's childhood vaccination programme, discussing and clarifying the severity principle in the childhood vaccination programme will be decisive for deciding whether the childhood vaccination programme should include this vaccination. Nevertheless, the vaccines are clearly effective and safe and can be relatively easily be added to Denmark's childhood vaccination programme. The modelling shows that the vaccination has an overall socioeconomic benefit for society but a net cost to the health system.

Project Status: Completed

Year Published: 2012

URL for published report: https://www.sst.dk/da/Udgivelser/2012/Vaccination-mod-rotavirus---en-medicinsk-teknologivurdering

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Denmark

Organisation Name: Danish Centre for Evaluation and Health Technology Assessment

Contact Address: National Board of Health, PO Box 1881, Islands Brygge 67, DK-2300 Copenhagen S, Denmark. Tel: 45 72 22 74 48; Fax: 45 72 22 74 07/67

Contact Name: dacehta@sst.dk

Contact Email: dacehta@sst.dk

Copyright: Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)